ArticleFuture oncology (London, England)Published
Real-world outcomes in metastatic HR+/HER2-, HER2+ and triple negative breast cancer after start of first-line therapy
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Future oncology (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Prognosis; Retrospective Studies; Female; Triple Negative Breast Neoplasms; Progression-Free Survival; Erb-b2 Receptor Tyrosine Kinases; Retrospective Study; Overall Survival; Triple Negative Breast Cancer; Real-world Data; Real-world Progression-free Survival
- PubMed ID
- 37191097
- Added to directory
- Source checked